Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,835 | Dovepress* | 4,355+ | 844 | 5,199 | |
| PubMed Central* | 480 | 97 | 577 | ||
| Totals | 4,835 | 941 | 5,776 | ||
| *Since 13 May 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar